These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 476621)
1. Galactosyl transferase activity in human transitional cell carcinoma lines and in benign and neoplastic human bladder epithelium. Plotkin GM; Wides RJ; Gilbert SL; Wolf G; Hagen IK; Prout GR Cancer Res; 1979 Oct; 39(10):3856-60. PubMed ID: 476621 [TBL] [Abstract][Full Text] [Related]
2. Galactosyl transferase activity in rat bladder transitional cell carcinoma lines and in exfoliated cells in urine during carcinogenesis and reversible hyperplasia. Plotkin GM; Gilbert SL; Wides RJ; Wolf G; Cohen SM; Fukushima S Cancer Biochem Biophys; 1980; 4(4):251-6. PubMed ID: 6778604 [TBL] [Abstract][Full Text] [Related]
3. Uridine 5'-diphosphate galactose: glycoprotein galactosyl transferase activity in exfoliated bladder epithelial cells in rats fed N-(4-(5-nitro-2-furyl)-2-thiazolyl) formamide. Plotkin GM; Brigham SC; Wolf G; Jacobs JB; Arai M Cancer Biochem Biophys; 1977; 2(2):59-63. PubMed ID: 99227 [TBL] [Abstract][Full Text] [Related]
4. Galactosyl transferase in benign and neoplastic human bladder mucosa. Hagen-Cook K; Prout GR; Plotkin GM; Gilbert SL; Wolf G Surg Forum; 1978; 29():627-9. PubMed ID: 122622 [No Abstract] [Full Text] [Related]
5. Galactosyltransferase activities in cultured urinary bladder tumor cells. Gmeiner BM; Wolf G Cancer Biochem Biophys; 1985 Dec; 8(2):103-18. PubMed ID: 3936613 [TBL] [Abstract][Full Text] [Related]
6. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas]. Zhan J; Tang XD Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218 [TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 isoenzyme mRNA expression pattern in human urinary bladder malignancies and normal urothelium. Brauers A; Manegold E; Buettner R; Baron JM; Merk HF; Jakse G Cancer Detect Prev; 2000; 24(4):356-63. PubMed ID: 11059566 [TBL] [Abstract][Full Text] [Related]
8. Sequential alkaline phosphatase changes in hyperplastic and neoplastic urothelium of mice fed 2-acetylaminofluorene. Highman B; Frith CH; Littlefield NA J Environ Pathol Toxicol; 1978; 1(3):223-31. PubMed ID: 722192 [No Abstract] [Full Text] [Related]
9. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes. Lee DH; Yang SC; Hong SJ; Chung BH; Kim IY Clin Cancer Res; 1998 Mar; 4(3):535-8. PubMed ID: 9533519 [TBL] [Abstract][Full Text] [Related]
10. [Studies on multiple mucosal biopsy in patients with bladder cancer. 1. Evaluation of the results of multiple mucosal biopsy in patients with bladder cancer and in vivo methylene blue staining]. Igawa M Hinyokika Kiyo; 1986 Nov; 32(11):1617-31. PubMed ID: 2435127 [TBL] [Abstract][Full Text] [Related]
11. Comparison of cell-associated and soluble galactosyltransferase isoenzymes from a human bladder transitional cell carcinoma line. Gmeiner B; Wolf G Cancer Res; 1987 May; 47(9):2311-6. PubMed ID: 3105874 [TBL] [Abstract][Full Text] [Related]
12. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression. King ED; Matteson J; Jacobs SC; Kyprianou N J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878 [TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
14. [The significance of the expression of cyclooxygenase-2 in bladder transitional cell carcinoma tissues]. Ren L; Hou SK; He LF; Ye HY; Guan KP Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1104-7. PubMed ID: 15498296 [TBL] [Abstract][Full Text] [Related]
15. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder]. Igawa M Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814 [TBL] [Abstract][Full Text] [Related]
16. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder. Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219 [TBL] [Abstract][Full Text] [Related]
17. Blood group ABO-related glycosylation of urothelial cell lines: immunocytological, enzymatic, and genetic characterization. Meldgaard P; Holmes EH; Bennett EP; Clausen H; Zeuthen J; Wolf H; Orntoft TF Cancer Res; 1994 May; 54(9):2440-7. PubMed ID: 8162594 [TBL] [Abstract][Full Text] [Related]
18. Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder. Margulis V; Shariat SF; Ashfaq R; Thompson M; Sagalowsky AI; Hsieh JT; Lotan Y J Urol; 2007 Mar; 177(3):1163-8. PubMed ID: 17296438 [TBL] [Abstract][Full Text] [Related]
19. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder]. Igawa M Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815 [TBL] [Abstract][Full Text] [Related]
20. The cytology of transitional cell carcinoma of the urinary bladder. Kern WH Acta Cytol; 1975; 19(5):420-8. PubMed ID: 1058612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]